fda drug shortage list tirzepatide Compounders lose battle over Eli Lilly weight loss and FDA says shortage of GLP-1

How to Choose the Right Option Since compounded semaglutide is no longer legally available as of May 2025, patients should consult healthcare professionals about FDA-approved options like Wegovy, which may now have improved availability and potential cost assistance programs

The COST-FACIT measure assesses financial toxicity, and individual items on occupational function, social determinants of health, and caregiver availability are captured

Safer DL, Adler S, Dalai SS, Bentley JP, Toyama H, Paraito S, Najarian T

What the evidence actually shows Research on probiotics and GLP-1 medications specifically is limited but growing

For many Canadians managing busy professional lives, this support for cellular energy can be a game-changer for daily stamina